Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Sep 24;373(13):1270-1.
doi: 10.1056/NEJMc1509660.

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, F Stephen Hodi, Jedd D Wolchok
Free article
Comment

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin et al. N Engl J Med. .
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, Ferrucci PF, Hill A, Wagstaff J, Carlino MS, Haanen JB, Maio M, Marquez-Rodas I, McArthur GA, Ascierto PA, Long GV, Callahan MK, Postow MA, Grossmann K, Sznol M, Dreno B, Bastholt L, Yang A, Rollin LM, Horak C, Hodi FS, Wolchok JD. Larkin J, et al. N Engl J Med. 2015 Jul 2;373(1):23-34. doi: 10.1056/NEJMoa1504030. Epub 2015 May 31. N Engl J Med. 2015. PMID: 26027431 Free PMC article. Clinical Trial.
  • Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    Valsecchi ME. Valsecchi ME. N Engl J Med. 2015 Sep 24;373(13):1270. doi: 10.1056/NEJMc1509660. N Engl J Med. 2015. PMID: 26398077 No abstract available.

MeSH terms

Substances